Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

November Monthly Update for Researchers

RFP Pharmacodynamic Biomarker Development:
LOI submission deadline is December 1, 2021


FARA is issuing a request for proposal (RFP) to support clinical drug development programs in Friedreich’s ataxia (FRDA) by promoting the discovery of technologies to measure frataxin or surrogates of frataxin in inaccessible and disease relevant tissues.
This RFP supports the discovery and validation of non-invasive and quantitative methodologies to measure the following in FRDA affected tissues (brain, spinal cord or heart):

  • Frataxin protein levels
  • Biochemical activities dependent on/downstream of frataxin function that can be surrogates of frataxin in inaccessible tissues.

More...

Read the full November Monthly Update for Researchers
 
 

SHARE

FacebookTwitterLinkedInYoutube

News & Press Archives

Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator